Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lujun Shen

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Medicine|July 12, 2016
A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasisZixun Zeng, Lujun Shen, Yue Wang, et al.
Journal of Cancer Research and Therapeutics|December 31, 2025
Microwave ablation combined with transarterial embolization for retroperitoneal inflammatory myofibroblastic tumor: A case report on complete responseChangqing Zhou, Shuanggang Chen, Lujun Shen, et al.
Journal of Cancer Research and Therapeutics|June 1, 2022
Feasibility and efficacy of superconducting open-configuration magnetic resonance-guided microwave ablation of malignant liver tumors with real-time imaging sequencesHui Yuan, Lujun Shen, Han Qi, et al.
Journal of Cancer Research and Therapeutics|June 1, 2020
Transcatheter arterial infusion of anti-programmed cell death 1 antibody pembrolizumab combined with temozolomide or nab-paclitaxel in patient with primary anorectal malignant melanoma: Four case reportsShuanggang Chen, Xiaoshi Zhang, Lujun Shen, et al.
Cancer Immunology, Immunotherapy : CII|December 4, 2018
The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinomaBoyang Chang, Tao Huang, Huajun Wei, et al.
BMC Medicine|May 9, 2025
Hepatic artery infusion of FOLFOX chemotherapy plus camrelizumab combined with sorafenib for advanced hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (Double-IA-001): a phase II trialLujun Shen, Fei Cao, Ying Liu, et al.
Neoplasma|November 25, 2025
Efficacy and safety of adebrelimab plus bevacizumab in combination with hepatic artery infusion chemotherapy for advanced stage hepatocellular carcinoma: a retrospective cohort studyChen Li, Letao Lin, Shuanggang Chen, et al.
Cancer Informatics|October 18, 2024
Machine Learning for Dynamic Prognostication of Patients With Hepatocellular Carcinoma Using Time-Series Data: Survival Path Versus Dynamic-DeepHit HCC ModelLujun Shen, Yiquan Jiang, Tao Zhang, et al.
Frontiers in Immunology|June 27, 2025
PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacyFei Cao, Chunyong Wen, Yujia Wang, et al.
Radiology|March 30, 2016
Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal CarcinomaLujun Shen, Wang Li, Siyang Wang, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Medicine|July 12, 2016
A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasisZixun Zeng, Lujun Shen, Yue Wang, et al.
Journal of Cancer Research and Therapeutics|December 31, 2025
Microwave ablation combined with transarterial embolization for retroperitoneal inflammatory myofibroblastic tumor: A case report on complete responseChangqing Zhou, Shuanggang Chen, Lujun Shen, et al.
Journal of Cancer Research and Therapeutics|June 1, 2022
Feasibility and efficacy of superconducting open-configuration magnetic resonance-guided microwave ablation of malignant liver tumors with real-time imaging sequencesHui Yuan, Lujun Shen, Han Qi, et al.
Journal of Cancer Research and Therapeutics|June 1, 2020
Transcatheter arterial infusion of anti-programmed cell death 1 antibody pembrolizumab combined with temozolomide or nab-paclitaxel in patient with primary anorectal malignant melanoma: Four case reportsShuanggang Chen, Xiaoshi Zhang, Lujun Shen, et al.
Cancer Immunology, Immunotherapy : CII|December 4, 2018
The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinomaBoyang Chang, Tao Huang, Huajun Wei, et al.
BMC Medicine|May 9, 2025
Hepatic artery infusion of FOLFOX chemotherapy plus camrelizumab combined with sorafenib for advanced hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (Double-IA-001): a phase II trialLujun Shen, Fei Cao, Ying Liu, et al.
Neoplasma|November 25, 2025
Efficacy and safety of adebrelimab plus bevacizumab in combination with hepatic artery infusion chemotherapy for advanced stage hepatocellular carcinoma: a retrospective cohort studyChen Li, Letao Lin, Shuanggang Chen, et al.
Cancer Informatics|October 18, 2024
Machine Learning for Dynamic Prognostication of Patients With Hepatocellular Carcinoma Using Time-Series Data: Survival Path Versus Dynamic-DeepHit HCC ModelLujun Shen, Yiquan Jiang, Tao Zhang, et al.
Frontiers in Immunology|June 27, 2025
PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacyFei Cao, Chunyong Wen, Yujia Wang, et al.
Radiology|March 30, 2016
Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal CarcinomaLujun Shen, Wang Li, Siyang Wang, et al.
Pageof 10